Neurocrine Biosciences (NBIX) Tops Q3 EPS by 58c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $154.03 --0%
EPS Growth %: -12.4%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -12.4%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $2.17, $0.58 better than the analyst estimate of $1.59. Revenue for the quarter came in at $794.9 million versus the consensus estimate of $748.62 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic jumps on earnings beat and raised guidance
- Boot Barn (BOOT) Reiterated at Overweight by JPMorgan as New Marketing Launched
- BofA Securities Resumes Element Solutions (ESI) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
